Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Atelerix
    15 April 2026

    Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

    Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the regionExpands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and research collaborationsS...

    logo
    14 April 2026

    Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform

    ·       Proceeds will help enhance workflows and expand single-cell functional assay portfolio·       Brad Crutchfield joins as advisor to support early access growth and  global launch ...

    bio-rad
    14 April 2026

    Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring

    Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications ...

     quantum computer
    10 April 2026

    Genome loaded onto a quantum computer in world first

    Sanger Institute team and their collaborators have successfully loaded the Hepatitis D viral genome on a quantum computer. ...

    ELRIG Logo
    14 April 2026

    ELRIG announces inaugural US Drug Discovery Conference

    • Free-to-attend event takes place at Pfizer in Cambridge, MA from 16–17 June • Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets ...

    BioUK logo
    14 April 2026

    OBN rebrands to BioUK in alignment with its mission to catalyse success in UK life sciences

    ·        The new name reflects the national reach of the UK life science membership organisation and leverages its wide and long-established portfolio of Bio-prefixed events ·        Announcement follows sustaine...

    Transmission Electron microscopic image of Mpox virus particles Credit: CDC/ National Institute of Allergy and Infectious Diseases (NIAID)
    14 April 2026

    ProImmune collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research

    Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments ...

    Michael Lukesch, Founder and CEO at VALANX Biotech. Dr Klaus Orlinger, Chief Scientific Officer at VALANX Biotech.  Dr John Lambert, Chair of the Scientific Advisory Board at VALANX Biotech
    14 April 2026

    VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

    John Lambert, Morris Rosenberg and Peter de Waele appointed as Chair and members of the SAB respectivelySAB provides scientific expertise and drug development experience, supporting advancement of the Company’s GoldenSite™ conjugation platform and its LIV-1 targeting lead program VLX-AD...

    a glass award
    13 April 2026

    Oil, Inflation, and the innovation budget question: what UK-China life sciences collaboration looks like when conditions tighten

    Excellence First Enterprise Consultancy (EFEC). When oil moves sharply, life sciences people can be tempted to see it as someone else’s problem. Energy is macroeconomics; biotech and MedTech are innovation. But that separation is usually an illusion. ...

    SPT Labtech’s firefly®+ in use at EMBL GeneCore
    13 April 2026

    SPT Labtech and EMBL GeneCore collaborate to advance fully walkaway automation in genomics workflows

    firefly+ liquid handling platform installed at EMBL GeneCoreCollaboration to enable more streamlined end-to-end workflows while maintaining sample integrityCambridge, UK, and Heidelberg, Germany, 13 April 2026: SPT Labtech, a global leader in the design and development of laboratory aut...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 21
    • Page 22
    • Current page 23
    • Page 24
    • Page 25
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS